Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02279433
Title A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Chao Family Comprehensive Cancer Center of Orange California 92868 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Inst. Boston Massachusetts 02215 United States Details
New York University New York New York 10016 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field